Viridian Therapeutics, Inc. VRDN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s current ratio?
- Viridian Therapeutics, Inc. (VRDN) reported current ratio of 15.1× in Q1 2026.
- How has Viridian Therapeutics, Inc.'s current ratio changed year-over-year?
- Viridian Therapeutics, Inc.'s current ratio decreased by 22.3% year-over-year, from 19.5× to 15.1×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s current ratio has grown at a 0.8% compound annual growth rate (CAGR), from 12.1× to 12.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.